Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

A MOTHER has revealed that she took the ‘golden dose’ of Mounjaro and is now urging others to not make the same mistake. Kate ...

A GLP-1/glucagon dual agonist induced significant weight loss and improved multiple cardiometabolic parameters for adults ...

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

Orforglipron is a small‑molecule, nonpeptide GLP‑1 receptor agonist taken once daily, and it skips some of the hassles that ...

Why Am I Not Losing Weight on Wegovy®? How to Get Results Key takeaways: Not losing weight on Wegovy® could be due to dose, ...

Eli Lilly's tirzepatide acts on two hormonal pathways, so it's called a dual GIP/GLP-1 receptor agonist, and it entered the ...

A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...